Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ketamine versus midazolam for spider phobia during virtual reality exposure
ACTRN12620000361909Phase 2Not yet recruiting
- Sponsor
- University of Otago
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ketamine and midazolam in specific phobia and Specific phobia animal type (2 arms), sponsored by University of Otago. Primary endpoint: Change in anxiety ratings. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
ketaminemidazolam
03
Conditions
specific phobiaSpecific phobia animal type
Beyond the preview
Go deeper on ACTRN12620000361909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000361909.